{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T02:35:48Z","timestamp":1772505348705,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"am","delay-in-days":312,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014161","name":"Conseil R\u00e9gional Hauts-de-France","doi-asserted-by":"publisher","award":["NP0020070"],"award-info":[{"award-number":["NP0020070"]}],"id":[{"id":"10.13039\/501100014161","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ejmech.2022.114515","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T05:43:19Z","timestamp":1654494199000},"page":"114515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Design and synthesis of water-soluble prodrugs of rifabutin for intraveneous administration"],"prefix":"10.1016","volume":"238","author":[{"given":"Kevin","family":"Antraygues","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Maingot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Schellhorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Trebosc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Gitzinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Deprez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Defert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn E.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyne","family":"Bourotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Lociuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0784-0462","authenticated-orcid":false,"given":"Nicolas","family":"Willand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2022.114515_bib1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/clinids\/22.Supplement_1.S3","article-title":"Antimicrobial activity of rifabutin","volume":"22","author":"Kunin","year":"1996","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114515_bib2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/jac\/31.5.799-a","article-title":"Comparative activity of rifabutin and rifampicin against gram-negative bacteria that have damaged or defective outer membranes","volume":"31","author":"Vaara","year":"1993","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114515_bib3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.tube.2011.05.002","article-title":"Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro","volume":"91","author":"Gill","year":"2011","journal-title":"Tuberculosis"},{"issue":"12","key":"10.1016\/j.ejmech.2022.114515_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.12998\/wjcc.v2.i12.787","article-title":"Antimicrobial resistance in acinetobacter baumannii: from bench to bedside","volume":"2","author":"Lin","year":"2014","journal-title":"World J. Clin. Cases WJCC"},{"key":"10.1016\/j.ejmech.2022.114515_bib5","author":"World Health Organization"},{"issue":"42","key":"10.1016\/j.ejmech.2022.114515_bib6","doi-asserted-by":"crossref","first-page":"10750","DOI":"10.1073\/pnas.1810137115","article-title":"The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis","volume":"115","author":"Janes","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.ejmech.2022.114515_bib7","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41564-020-0737-6","article-title":"A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant acinetobacter baumannii","volume":"5","author":"Luna","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114515_bib8","article-title":"Pharmacokinetics and pharmacodynamics of BV100 in neutropenic mouse lung infection models","author":"Muller","year":"2021","journal-title":"ECCMID 2021 congress"},{"issue":"8","key":"10.1016\/j.ejmech.2022.114515_bib9","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1128\/AAC.33.8.1237","article-title":"Pharmacokinetics of rifabutin","volume":"33","author":"Skinner","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114515_bib13","series-title":"Phosphonated Rifamycins and Uses Thereof for the Prevention and Treatment of Bone and Joint Infections","author":"Dietrich","year":"2010"},{"key":"10.1016\/j.ejmech.2022.114515_bib14","series-title":"Phosphonated Rifamycins and Uses Thereof for the Prevention and Treatment of Bone and Joint Infections","author":"Dietrich","year":"2011"},{"issue":"2","key":"10.1016\/j.ejmech.2022.114515_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bmc.2008.12.006","article-title":"Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H37Rv, MDR and NRP Mycobacterium tuberculosis","volume":"17","author":"Figueiredo","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114515_bib16","series-title":"Derivatives of rifabutine useful as antimicrobial agents","volume":"15","author":"Medeiros","year":"2004"},{"issue":"12","key":"10.1016\/j.ejmech.2022.114515_bib17","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1002\/cphc.201300262","article-title":"Evaluation of the structure-activity relationship of rifabutin and analogs: a drug-membrane study","volume":"14","author":"Pinheiro","year":"2013","journal-title":"Chemphyschem Eur. J. Chem. Phys. Phys. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114515_bib18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ijpharm.2013.06.018","article-title":"Interactions of N\u2019-Acetyl-Rifabutin and N\u2019-Butanoyl-Rifabutin with lipid bilayers: a synchrotron X-ray study","volume":"453","author":"Pinheiro","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2022.114515_bib19","series-title":"Phosphonated Rifamycins and Uses Thereof for the Prevention and Treatment of Bone and Joint Infections","author":"Rose","year":"2007"},{"issue":"2","key":"10.1016\/j.ejmech.2022.114515_bib20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7164\/antibiotics.37.178","article-title":"Correlation of structure and activity in ansamycins: molecular structure of cyclized rifamycin SV","volume":"37","author":"Arora","year":"1984","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"5","key":"10.1016\/j.ejmech.2022.114515_bib21","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/anie.200461657","article-title":"Single-triggered trimeric prodrugs","volume":"44","author":"Haba","year":"2005","journal-title":"Angew. Chem. Int. Ed."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114515_bib22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1023\/A:1015890809507","article-title":"Amine prodrugs which utilize hydroxy amide lactonization. II. A potential esterase-sensitive amide prodrug","volume":"8","author":"Amsberry","year":"1991","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"22","key":"10.1016\/j.ejmech.2022.114515_bib23","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1016\/j.bmcl.2008.06.015","article-title":"A highly sensitive fluorogenic probe for cytochrome P450 activity in live cells","volume":"18","author":"Yatzeck","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"6","key":"10.1016\/j.ejmech.2022.114515_bib24","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.bmcl.2005.01.065","article-title":"Cyclization-activated prodrugs. Synthesis, reactivity and toxicity of dipeptide esters of paracetamol","volume":"15","author":"Santos","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"2","key":"10.1016\/j.ejmech.2022.114515_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1399-3011.2003.00111.x","article-title":"Cyclosporin A prodrugs: design, synthesis and biophysical properties","volume":"63","author":"Hamel","year":"2004","journal-title":"J. Pept. Res."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114515_bib26","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/bip.21418","article-title":"Synthesis and characterization of ester-based prodrugs of glucagon-like peptide 1","volume":"94","author":"De","year":"2010","journal-title":"Biopolymers"},{"issue":"2","key":"10.1016\/j.ejmech.2022.114515_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0300-483X(81)90119-0","article-title":"Toxicity of aspartame and its diketopiperazine for wistar rats by dietary administration for 104 weeks","volume":"21","author":"Ishii","year":"1981","journal-title":"Toxicology"},{"key":"10.1016\/j.ejmech.2022.114515_bib28","series-title":"Method for Selective Removal of Dibenzofulvene Derivative","author":"Daisuke","year":"2010"},{"issue":"2","key":"10.1016\/j.ejmech.2022.114515_bib29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1021\/jm00164a031","article-title":"Synthesis and biological activity of atrial natriuretic factor Analogues: effect of modifications to the disulfide bridge","volume":"33","author":"DiMaio","year":"1990","journal-title":"J. Med. Chem."},{"issue":"32","key":"10.1016\/j.ejmech.2022.114515_bib30","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1016\/j.tetlet.2015.06.030","article-title":"A convenient method for phosphorylation using triallyl phosphite","volume":"56","author":"Li","year":"2015","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2022.114515_bib31","series-title":"Dual Protected Pro-coelenterazine Substrates","author":"Meisenheimer","year":"2018"},{"key":"10.1016\/j.ejmech.2022.114515_bib32","series-title":"Phospholipid Ether Conjugates as Cancer-Targeting Drug Vehicles","author":"Longcor","year":"2021"},{"key":"10.1016\/j.ejmech.2022.114515_bib33","series-title":"Compounds Useful in HIV Therapy","author":"De La Rosa","year":"2020"},{"issue":"16","key":"10.1016\/j.ejmech.2022.114515_bib34","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1039\/C7OB00121E","article-title":"Syntheses and kinetic studies of cyclisation-based self-immolative spacers","volume":"15","author":"Huvelle","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2022.114515_bib35","series-title":"Prodrugs of 1,4-benzodiazepinone Compounds","author":"Gavai","year":"2014"},{"issue":"5","key":"10.1016\/j.ejmech.2022.114515_bib36","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/cbic.200700644","article-title":"Self-cleavable bioluminogenic luciferin phosphates as alkaline phosphatase reporters","volume":"9","author":"Zhou","year":"2008","journal-title":"Chembiochem"},{"issue":"12","key":"10.1016\/j.ejmech.2022.114515_bib37","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1002\/anie.201309633","article-title":"A photochromic agonist for \u03bc-opioid receptors","volume":"53","author":"Sch\u00f6nberger","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"issue":"51","key":"10.1016\/j.ejmech.2022.114515_bib38","doi-asserted-by":"crossref","first-page":"12786","DOI":"10.1002\/anie.201206916","article-title":"Construction of an all-carbon quaternary stereocenter by the peptide-catalyzed asymmetric michael addition of nitromethane to \u03b2-disubstituted \u03b1,\u03b2-unsaturated aldehydes","volume":"51","author":"Akagawa","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114515_bib39","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0960-894X(00)80058-X","article-title":"Novel water soluble phosphate prodrugs of Taxol\u00ae possessing in vivo antitumor activity","volume":"3","author":"Ueda","year":"1993","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"8","key":"10.1016\/j.ejmech.2022.114515_bib40","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1039\/C8RA08594C","article-title":"Interspecies differences in stability kinetics and plasma esterases involved in hydrolytic activation of curcumin diethyl disuccinate, a prodrug of curcumin","volume":"9","author":"Bhuket","year":"2019","journal-title":"RSC Adv."},{"issue":"9","key":"10.1016\/j.ejmech.2022.114515_bib41","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1124\/dmd.114.057372","article-title":"Hepatic, intestinal, renal, and plasma hydrolysis of prodrugs in human, cynomolgus monkey, dog, and rat: implications for in vitro-in vivo extrapolation of clearance of prodrugs","volume":"42","author":"Nishimuta","year":"2014","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2022.114515_bib42","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1021\/acsmedchemlett.7b00189","article-title":"Synthesis and biological evaluation of paclitaxel and camptothecin prodrugs on the basis of 2-nitroimidazole","volume":"8","author":"Jin","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114515_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12793\/tcp.2018.26.1.1","article-title":"Understanding the pharmacokinetics of prodrug and metabolite","volume":"26","author":"Cho","year":"2018","journal-title":"Transl. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114515_bib44","series-title":"In Vivo Efficacy of BV100 in Mouse Models of Acinetobacter Baumannii Infections. ECCMID 2021 Congress","author":"Dale","year":"2021"},{"issue":"19","key":"10.1016\/j.ejmech.2022.114515_bib45","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.3390\/molecules24193419","article-title":"Benzoxaboroles\u2014novel autotaxin inhibitors","volume":"24","author":"Kralji\u0107","year":"2019","journal-title":"Molecules"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422004172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422004172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T14:14:14Z","timestamp":1728396854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422004172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":42,"alternative-id":["S0223523422004172"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114515","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of water-soluble prodrugs of rifabutin for intraveneous administration","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114515"}}